Literature DB >> 18032011

Life and death decisions by the E2F transcription factors.

Phillip J Iaquinta1, Jacqueline A Lees.   

Abstract

The E2F transcription factors are critical regulators of genes required for appropriate progression through the cell cycle, and in special circumstances they can also promote the expression of another class of genes that function in the apoptotic program. Since E2Fs can initiate both cell proliferation and cell death, it is not surprising that the pro-apoptotic capacity of these proteins is subject to complex regulation. Recent study has expanded our knowledge of the factors influencing E2F-induced apoptosis as well as downstream targets of E2F in this process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032011      PMCID: PMC2268988          DOI: 10.1016/j.ceb.2007.10.006

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  64 in total

1.  E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.

Authors:  H Müller; A P Bracken; R Vernell; M C Moroni; F Christians; E Grassilli; E Prosperini; E Vigo; J D Oliner; K Helin
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

2.  E2F-1 functions in mice to promote apoptosis and suppress proliferation.

Authors:  S J Field; F Y Tsai; F Kuo; A M Zubiaga; W G Kaelin; D M Livingston; S H Orkin; M E Greenberg
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

3.  Tumor induction and tissue atrophy in mice lacking E2F-1.

Authors:  L Yamasaki; T Jacks; R Bronson; E Goillot; E Harlow; N J Dyson
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

4.  Distinct roles for E2F proteins in cell growth control and apoptosis.

Authors:  J DeGregori; G Leone; A Miron; L Jakoi; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

5.  Role for E2F in DNA damage-induced entry of cells into S phase.

Authors:  Y Huang; T Ishiko; S Nakada; T Utsugisawa; T Kato; Z M Yuan
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

6.  Induction of DNA synthesis and apoptosis are separable functions of E2F-1.

Authors:  A C Phillips; S Bates; K M Ryan; K Helin; K H Vousden
Journal:  Genes Dev       Date:  1997-07-15       Impact factor: 11.361

7.  Role of the p53-homologue p73 in E2F1-induced apoptosis.

Authors:  T Stiewe; B M Pützer
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

8.  A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection.

Authors:  J W Zhu; D DeRyckere; F X Li; Y Y Wan; J DeGregori
Journal:  Cell Growth Differ       Date:  1999-12

9.  PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family.

Authors:  L D Attardi; E E Reczek; C Cosmas; E G Demicco; M E McCurrach; S W Lowe; T Jacks
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

10.  E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.

Authors:  J K Hsieh; S Fredersdorf; T Kouzarides; K Martin; X Lu
Journal:  Genes Dev       Date:  1997-07-15       Impact factor: 11.361

View more
  155 in total

1.  The role of E2F-1 and downstream target genes in mediating ischemia/reperfusion injury in vivo.

Authors:  Ekaterini Angelis; Peng Zhao; Rui Zhang; Joshua I Goldhaber; W Robb Maclellan
Journal:  J Mol Cell Cardiol       Date:  2011-09-22       Impact factor: 5.000

Review 2.  The retinoblastoma tumor suppressor and stem cell biology.

Authors:  Julien Sage
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

3.  The ancient function of RB-E2F pathway: insights from its evolutionary history.

Authors:  Lihuan Cao; Bo Peng; Lei Yao; Xinming Zhang; Kuan Sun; Xianmei Yang; Long Yu
Journal:  Biol Direct       Date:  2010-09-20       Impact factor: 4.540

Review 4.  Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.

Authors:  Jiao Zhang; Yan-Hua Chen; Qun Lu
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

5.  PNUTS knockdown potentiates the apoptotic effect of Roscovitine in breast and colon cancer cells.

Authors:  Gabriel De Leon; Margaret Cavino; Mikilyn D'Angelo; Nancy A Krucher
Journal:  Int J Oncol       Date:  2010-05       Impact factor: 5.650

6.  MEF2D deficiency in neonatal cardiomyocytes triggers cell cycle re-entry and programmed cell death in vitro.

Authors:  Nelsa L Estrella; Amanda L Clark; Cody A Desjardins; Sarah E Nocco; Francisco J Naya
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

Review 7.  E2F1: a promising regulator in ovarian carcinoma.

Authors:  Lei Zhan; Yu Zhang; Wenyan Wang; Enxue Song; Yijun Fan; Bing Wei
Journal:  Tumour Biol       Date:  2016-01-09

8.  Two Distinct E2F Transcriptional Modules Drive Cell Cycles and Differentiation.

Authors:  Maria C Cuitiño; Thierry Pécot; Daokun Sun; Raleigh Kladney; Takayuki Okano-Uchida; Neelam Shinde; Resham Saeed; Antonio J Perez-Castro; Amy Webb; Tom Liu; Soo In Bae; Linda Clijsters; Nicholas Selner; Vincenzo Coppola; Cynthia Timmers; Michael C Ostrowski; Michele Pagano; Gustavo Leone
Journal:  Cell Rep       Date:  2019-05-23       Impact factor: 9.423

9.  Competing memories of mitogen and p53 signalling control cell-cycle entry.

Authors:  Hee Won Yang; Mingyu Chung; Takamasa Kudo; Tobias Meyer
Journal:  Nature       Date:  2017-09-06       Impact factor: 49.962

Review 10.  Nanos genes and their role in development and beyond.

Authors:  Evi De Keuckelaere; Paco Hulpiau; Yvan Saeys; Geert Berx; Frans van Roy
Journal:  Cell Mol Life Sci       Date:  2018-02-03       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.